3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
49
Gastrointestinal
8
Genitourinary
7
Thoracic
3
Plasma cell
2
NET
2
Gynecologic
2
Endocrine
2
Breast
2
Other solid neoplasm
1
Head & Neck
1
Dermatologic
1
CNS
1
Conditions
Squamous Cell Carcinoma of Head and Neck
630
Head and Neck Neoplasms
609
Carcinoma, Non-Small-Cell Lung
201
Thyroid Neoplasms
196
Melanoma
145
Nasopharyngeal Carcinoma
133
Oropharyngeal Neoplasms
130
Colorectal Neoplasms
127
Mouth Neoplasms
126
Neoplasms
112
Breast Neoplasms
112
Lung Neoplasms
106
Ovarian Neoplasms
104
Uterine Cervical Neoplasms
99
Neoplasm Metastasis
93
Carcinoma, Squamous Cell
85
Carcinoma, Renal Cell
83
Stomach Neoplasms
82
Triple Negative Breast Neoplasms
76
Pancreatic Neoplasms
71
Esophageal Neoplasms
69
Laryngeal Neoplasms
68
Endometrial Neoplasms
65
Urinary Bladder Neoplasms
59
Sarcoma
57
Thyroid Cancer, Papillary
54
Prostatic Neoplasms
52
Salivary Gland Neoplasms
49
Carcinoma, Transitional Cell
46
Carcinoma, Hepatocellular
45
Interventions
pembrolizumab
1
Histamine H2 Antagonists
1
Famotidine
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liposarcoma
×
Head & Neck
×
1 year
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled